When levels are low, patients may experience fatigue, brain fog, or mood changes
Patients experiencing weight gain or having excess weight, despite weight loss efforts, may be considered for this therapy, especially if they have underlying metabolic conditions or hormonal imbalances that impact their weight management
sclerotiorum naturally infects, we inoculated the strains expressing SsCm1-GFP on wild-type N
Moreover, continued bone metabolism impairment over time in the aftermath of weight loss has been reported in postmenopausal women despite maintaining a stable weight, suggesting a progressive or even delayed effect [7]
Despite its availability, Wegovy has faced frequent supply shortages, making access a potential issue for patients looking to manage their weight effectively